Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 6, 2025
Reporting Period: The filing references sales and operating results for the three and nine-month periods ended September 30, 2025.
Key Financial Metrics
This Form 8-K serves as a notification of a press release (Exhibit 99.1) containing financial results. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these details.
Material Changes
The filing does not contain specific data regarding material changes versus prior periods. It solely indicates that results for the three and nine months ended September 30, 2025, have been reported in a separate press release.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release issued on November 6, 2025, which contains the company's sales and operating results.
Legal Status: In accordance with General Instruction B.2 to Form 8-K, the information in Item 2.02 and the attached exhibits is deemed "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Guidance/Risks: No specific guidance, outlook, or risk factors are detailed within the text of this 8-K form.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 6, 2025) for actual revenue, earnings, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter growth rates in the attached press release.
- Check for any forward-looking statements or updated guidance included in the press release.
- Confirm the status of the company as an emerging growth company (indicated as unchecked in the filing).